Single tube liquid biopsy for advanced non-small cell lung cancer.
Adult
Aged
Aged, 80 and over
Biomarkers, Tumor
/ blood
Carcinoma, Non-Small-Cell Lung
/ blood
Case-Control Studies
Circulating Tumor DNA
/ blood
Epithelial Cell Adhesion Molecule
/ blood
Female
Humans
Liquid Biopsy
/ methods
Lung Neoplasms
/ blood
Male
Middle Aged
Mutation
Neoplasm Staging
Neoplastic Cells, Circulating
/ pathology
Survival Rate
EpCAM
biomarkers
circulating tumor DNA
circulating tumor cells
extracellular vesicles
liquid biopsy
non-small cell lung cancer
survival
Journal
International journal of cancer
ISSN: 1097-0215
Titre abrégé: Int J Cancer
Pays: United States
ID NLM: 0042124
Informations de publication
Date de publication:
15 06 2019
15 06 2019
Historique:
received:
24
07
2018
revised:
26
10
2018
accepted:
19
11
2018
pubmed:
12
12
2018
medline:
9
10
2019
entrez:
12
12
2018
Statut:
ppublish
Résumé
The need for a liquid biopsy in non-small cell lung cancer (NSCLC) patients is rapidly increasing. We studied the relation between overall survival (OS) and the presence of four cancer biomarkers from a single blood draw in advanced NSCLC patients: EpCAM
Substances chimiques
Biomarkers, Tumor
0
Circulating Tumor DNA
0
Epithelial Cell Adhesion Molecule
0
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3127-3137Informations de copyright
© 2018 UICC.